Mr. Wang (Wallace) L. Lee tendered his resignation as the Chief Financial Officer of China SXT Pharmaceuticals, Inc. with immediate effect. Mr. Lee's decision to resign was not a result of any disagreements with the Company on any matter related to the operations, policies, or practices of the Company. On the same date, Mr. Xiaodong Pan was appointed as the new CFO of the Company, effective immediately.

Mr. Pan has served as the Finance Director of Jiangsu Suxuantang Pharmaceutical Co. Ltd., the consolidated variable interests entity of the Company in China, since March 2015.